TateEDPranzatelliMRVerhulstSJ. Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome. J Child Neurol. 2012;27:875–884.
2.
BrunklausAPohlKZuberiSMde SousaC. Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life. Pediatrics. 2011;128:e388–e394.